Catherine Mazzacco - Jun 30, 2023 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Director
Signature
/s/ Krish Krishnan, as attorney-in-fact for Catherine Mazzacco
Stock symbol
KRYS
Transactions as of
Jun 30, 2023
Transactions value $
$0
Form type
4
Date filed
7/3/2023, 04:35 PM
Previous filing
Jul 3, 2023
Next filing
Jun 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRYS Stock Option (Right to Buy) Award $0 +2.18K $0.00 2.18K Jun 30, 2023 Common Stock 2.18K $117.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were awarded on June 30, 2023 and vest in equal monthly tranches over a one-year period.